Th1 and Th2 cell responses of type 1 diabetes patients and healthy controls to human heat-shock protein 60 peptides AA437-460 and AA394-408

Inflammation Research

Volumn 54, Issue 10, 2005, Pages 415-419

  Szebeni, A ^a   Schloot, N ^b   Kecskemeti V ^a   Hosszufalusi N ^a   Panczel P ^a   Prohaszka Z ^a   Fust G ^a   Uray, K ^c   Hudecz, F ^c,d   Meierhoff, G ^b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^d EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Diabetes; Heat shock protein 60 p277; Interferon ; Interleukin 13

Indexed keywords

AMINO ACID; GAMMA INTERFERON; HEAT SHOCK PROTEIN 60; INTERLEUKIN 13; MITOGENIC AGENT; TETANUS TOXOID;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADULT; AGED; CASE-CONTROL STUDIES; CELLS, CULTURED; CHAPERONIN 60; DIABETES MELLITUS, TYPE 1; FEMALE; HEALTH; HUMANS; INTERFERON TYPE II; INTERLEUKIN-13; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; TH1 CELLS; TH2 CELLS;

EID: 27744606540     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-1362-9     Document Type: Article

References (27)

1. Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360-8.
2. Atkinson MA, Maclaren NK. The pathogenesis of insulin-dependent diabetes mellitus. N Engl J Med 1994; 331: 1428-36.
3. Elias D, Prigozin H, Polak N, Rapoport M, Lohse AW, Cohen IR. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin. Diabetes 1994; 43: 992-8.
4. Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 1990; 87: 1576-80.
5. Elias D, Cohen IR. The hsp60 peptide p277 arrest the autoimmune diabetes induced by the toxin Streptozotocin. Diabetes 1996; 45: 1168-72.
6. Elias D, Reshef T, Birk OS, Van Der Zee R, Walker MD, Cohen IR. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65 kDa heat shock protein. Proc Natl Acad Sci USA 1991; 88: 3088-91.
7. Elias D, Cohen IR. Peptide therapy for diabetes in NOD mice. Lancet 1994; 343: 704-6.
8. Birk OS, Elias D, Weiss AS, Rosen A, van-der Zee R, Walker MD et al. NOD mouse diabetes: The ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun 1996; 9: 159-66.
9. Elias D, Cohen IR. Treatment of autoimmune diabetes and insulitis in NOD mice with heat shock protein60 peptide p277. Diabetes 1995; 44: 1132-8.
10. Kotani R, Nagata M, Moriyama H, Nakayama M, Yamada K, Chowdhury SA et al. Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays. Diabetes Care 2002; 25: 1390-7.
11. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA et al. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/ IA-2 autoantibodies. Diabetes 1996; 45: 926-33.
12. Verge CF, Stenger D, Bonifacio E, Colman PG, Pilcher C, Bingley PJ et al. and Participating Laboratories. Combined use of autoantibodies (IA-2 auto-antibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell anti-bodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop, Diabetes 1998; 47: 1857-66.
13. Leslie RDG, Atkinson MA, Notkins AL. Autoantigens IA-2 and GAD in type 1 (insulin-dependent) diabetes. Diabetologia 1999; 42: 3-14.
14. Kobayashi T, Tamemoto K, Nakanishi H, Kato N, Okubo M, Kajio H et al. Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 1993; 16: 780-8.
15. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR. Autoantibodies to glutamate acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin dependent on-set of disease. Diabetes 1993; 42: 359-62.
16. Horvath L, Cervenak L, Oroszlan M, Prohaszka Z, Uray K, Hudecz F et al. Antibodies against different epitopes of heat-shock protein 60 in children with type 1 diabetes mellitus. Immunol Lett 2002; 80: 155-62.
17. Miller BJ, Appel MC, O'Neil JJ, Wicker LS. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J Immunol 1988; 140: 52-8.
18. Christianson SW, Shultz LD, Leiter EH. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD. NON-Thy-1a donors. Diabetes 1993; 42: 44-55.
19. Abulafia-Lapid R, Elias D, Raz I, Keren-Zur Y, Atlan H, Cohen IR. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmun 1999; 12: 121-9.
20. Berman MA, Sandborg CI, Wang Z, Imfeld KL, Zaldivar F Jr, Dadufalza V et al. Decreased IL-4 production in new onset type I insulin-dependent diabetes mellitus. J Immunol 1996; 157: 4690-6.
21. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR. Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial. The Lancet 2001; 358: 1749-53.
22. Kaiser E, Colescott RL, Bossinger CD, Cook PI. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 1970; 34: 595-8.
23. Kaiser E, Bossinger CD, Colescott RL, Olser DB. Anal Chem Acta 1980; 118: 149-51.
24. Schloot NC, Meierhoff G, Karlsson Faresjo M, Ott P, Putnam A, Lehmann P et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 2003; 21: 365-76.
25. Meierhoff G, Ott PA, Lehmann PV, Schloot NC. Cytokine detection by ELISPOT: relevance for immunological studies in type 1 diabetes. Diabetes Metab Res 2002; 18: 367-80.
26. Hanifi-Moghaddam P, Schloot NC, Kappler S, Seissler J, Kolb H. An association of autoantibody status and serum cytokine levels in type 1 diabetes. Diabetes 2003; 52: 1137-42.
27. Zaccone P, Phillips J, Conget I, Gomis R, Haskins K, Minty A et al. Interleukin-13 prevents autoimmune diabetes in NOD mice. Diabetes 1999; 48: 1522-8.